Bookmark and Share

Linda  Jeng
 

Linda Jeng M.D., Ph.D.

Academic Title: Associate Professor
Primary Appointment: Medicine
Secondary Appointments: Pathology, Pediatrics
ljeng@som.umaryland.edu
Location: BRB 7-037
Phone: 410-706-4505
Lab: 410-706-3339

Personal History:

Linda Jo Bone Jeng, MD, PhD, is an associate professor of Medicine at the University of Maryland School of Medicine (UMSOM), with secondary appointments in the Departments of Pathology and Pediatrics. After earning her BA from the Whittier Scholars program with a focus on biochemistry at Whittier College, she received her MD at the University of Pennsylvania School of Medicine and her PhD in Cell and Molecular Biology at the University of Pennsylvania Biomedical Graduate Program. She subsequently completed her residency training in Pediatrics and Medical Genetics at the University Hospitals of Cleveland and Rainbow Babies Children's Hospital. Dr. Jeng completed additional fellowship training in Clinical Molecular Genetics at Case Western Reserve University (CASE) and is board-certified in clinical genetics and clinical molecular genetics by the American Board of Medical Genetics and Genomics. In 2005, she joined the faculty at CASE School of Medicine where she was the Assistant Director of the Center for Human Genetics Molecular Diagnostic Testing Laboratory. In 2008, she relocated to join the faculty at the University of California, San Francisco School of Medicine where she was the Director of Molecular Genetics, Medical Director of Molecular Diagnostics, and Assistant Director of Cytogenetics. In 2013, she joined the faculty at UMSOM. Currently she is Director of Medical Genomics in the Translational Genomics Laboratory within the Program for Personalized and Genomic Medicine and the Division of Endocrinology, Diabetes, and Nutrition. Dr. Jeng is also involved with medical genetics education, including teaching graduate students, medical students, residents, and fellows.

Dr. Jeng is a fellow of the American College of Medical Genetics and a member of the American Society of Human Genetics, the Association for Molecular Pathology (AMP), and the Association of Human and Medical Genetics. Dr. Jeng has served on the Training and Education and Clinical Practice (CPC) Committees for AMP and continues to serve currently as an ad hoc member of the CPC.

Research Interests:

Dr. Jeng is interested in the development of new molecular tests that can be offered in the clinical setting with a particular interest in clinical molecular genetics. She is especially interested in translational research and providing molecular support for research protocols as appropriate.

Clinical Speciality:

Clinical Molecular Genetics and Clinical Genetics


Publications:

  • Pua HH, Krishnamurthi S, Farrell J, Margeta M, Ursell PC, Powers M, Slavotinek AM, Jeng LJB. 2014. Novel interstitial 2.6 Mb deletion on 9q21 associated with multiple congenital anomalies. Am J Med Genet Part A 164A:237-242.
  • Glaser TS, Rauen KA, Jeng LJ, de Alba Campomanes AG. Lipodermoid in a patient with Emanuel syndrome. J AAPOS. 2013 Apr; 17(2):211-3.
  • Bermudez-Wagner K, Jeng LJ, Slavotinek AM, Sanford EF. 2p16.3 microdeletion with partial deletion of the neurexin-1 gene in a female with developmental delays, short stature, and a congenital diaphragmatic hernia. Clin Dysmorphol. 2013 Jan; 22(1):22-4.
  • Sanford EF, Bermudez-Wagner K, Jeng LJ, Rauen KA, Slavotinek AM. Congenital Diaphragmatic Hernia in Smith-Magenis Syndrome: A Possible Locus at Chromosome 17p11.2. Am J Med Genet A. 2011 Nov;155A(11):2816-2820.
  • Al-Kateb H, Hahn A, Gastier-Foster JM, Jeng L, McCandless SE, Curtis CA. Molecular Characterization of a Novel, de novo, Cryptic Interstitial Deletion on 19p13.3 in a Child with a Cutis Aplasia and Multiple Congenital Anomalies. Am J Med Genet A. 2010; 152A(12):3148-3153.
  • Noor A, Whibley A, Marshall CR, Gianakopoulos PJ, Piton A, Carson AR, Orlic-Milacic M, Lionel A, Sato D, Pinto D, Drmic I, Noakes C, Senman L, Zhang X, Mo R, Gauthier J, Crosbie J, Pagnamenta AT, Munson J, Estes AM, Fiebig A, Franke A, Schrieber S, Stewart AFR, Roberts R, McPherson R, Guter SJ, Cook EH, Dawson G, Schellenberg GD, Battaglia A, Maestrini E, Autism Genome Project Consortium, Jeng L, Hutchison T, Rajcan-Separovic E, Chudley AE, Lewis SME, Liu X, Holden J, Fernandez B, Zwaigenbaum L, Bryson SE, Roberts W, Szatmari P, Gallagher L, Stratton MR, Gecz J, Brady AF, Schwartz CE, Schachar RJ, Monaco AP, Rouleau GA, Hui C-C, Raymond FL, Scherer SW, and Vincent JB. Disruption at the PTCHD1 locus on Xp22.11 in autism spectrum disorder and intellectual disability. Sci Transl Med. 2010; 2(49);49ra68.
  • Demaree HA, Pu J, Jesberger J, Feeny N, Jeng L, Everhart DE, Duerk J, Tkach J. 5HTTLPR predicts left fusiform gyrus activation to positive emotional stimuli. Magn Reson Imaging. 2008 Oct 10.
  • Shinawi M, Shao L, Jeng LJ, Shaw CA, Patel A, Bacino C, Sutton VR, Belmont J, Cheung SW. Low-level mosaicism of trisomy 14: phenotypic and molecular characterization. Am J Med Genet A. 2008 Jun 1;146A(11):1395-1405.
  • Putcha GV, Bejjani BA, Bleoo S, Booker JK, Carey JC, Carson N, Das S, Dempsey MA, Gastier-Foster JM, Greinwald JH Jr, Hoffmann ML, Jeng LJ, Kenna MA, KhababaI, Lilley M, Mao R, Muralidharan K, Otani IM, Rehm HL, Schaefer F, Seltzer WK, Spector EB, Springer MA, Weck KE, Wenstrup RJ, Withrow S, Wu BL, Zariwala MA, Schrijver I. A multicenter study of the frequency and distribution of GJB2 and GJB6 mutations in a large North American cohort. Genet Med. 2007 Jul;9(7):413-426.
  • Jeng LJ, Balice-Gordon RJ, Messing A, Fischbeck KH, Scherer SS (2006). The effects of a dominant connexin32 mutant in myelinating Schwann cells. Mol Cell Neurosci;32(3):283-298.
  • Mehra S, Christ L, Jeng L, Zinn AB, Schwartz S (2005). Characterization of a familial balanced rec(13) in a child with mild MR and his half-sibling with two structurally rearranged chromosomes 13. Am J Med Genet A;137(2):217-221.
  • Scherer SS, Xu YT, Messing A, Willecke K, Fischbeck KH, Jeng LJ (2005). Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice. J Neurosci;25(6):1550-1559.